Metabolic Drug-Drug Interaction Potential of Macrolactin a and 7-O-Succinyl Macrolactin a Assessed by Evaluating Cytochrome P450 Inhibition and Induction and UDP-Glucuronosyltransferase Inhibition in Vitro

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00018-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Drug–drug Interactions of Budesonide: Inhibition and Induction of Transporters and Cytochrome P450 Enzymes

Xenobiotica
PharmacologyBiochemistryMutagenesisHealthMedicineToxicology
2017English

Fatal Poisoning Case Involving Drug Interaction Due to the Inhibition of Cytochrome P450

Vojnosanitetski Pregled
MedicinePharmacology
2019English

Plasma Exosomes and Drug Metabolic Cytochrome P450 Enzymes

Journal of Drug Metabolism & Toxicology
2015English

Inhibition and Inactivation of Cytochrome P450 2A6 and Cytochrome P450 2A13 by Menthofuran, Β-Nicotyrine and Menthol

Chemico-Biological Interactions
MedicineToxicology
2012English

Inhibition of Cytochrome P450 by Nitric Oxide.

Folia Pharmacologica Japonica
Pharmacology
1998English

Mechanism of Drug–Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer

Biochemistry
Biochemistry
2015English

Time-Dependent Inhibition of Human Drug Metabolizing Cytochromes P450 by Tricyclic Antidepressants

British Journal of Clinical Pharmacology
Pharmacology
2008English

African Genetic Diversity: Implications for Cytochrome P450-Mediated Drug Metabolism and Drug Development

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Retraction: Role of Cytochrome P450 in Drug Interactions

Nutrition and Metabolism
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy